* Stock is trading today above its 200d MA - first time since Nov 2016* Stock has underperfomed SX5E by 3.9% YTD / by 16.80% on 52w., Underperformed SX3E by another 3%* Beverage continue to Underperform the broader market but communications from integration & Synergies from SAB Deal could help the performance* 2017 Highs have been tested and broken today (103.12 - we traded up to 103.20)* Stock opened with a gap today ( 101.82/102.80) if they close above the 200d MA (102.30) could see an acceleration to check higher levels* 106.87 (3.8% higher) is the first level we should check on the upside - with an extension the 108 levels* Support is the 50d MA (100.84) and the bottom of the range where we trade 100.34.* Stock is trading Ex Div today and Reporting on Thu. 4th of May.I will buy the stock to play a bounce from here.See a quick chart below :
In reaction to disappointing earnings/guidance:
- SNAP -21.8%, MNKD -19.4%, BCEI -16.8%, KGJI -16.7%, QTM -16.6%, SANW -14.6%, AVNW -14.6%,NH -12.8%, SCON -12.2%, NVCN -12.1%, VSTO -12.1%, RGSE -11.9%, M -11.9%, FRSH -11.8%, RESN -11.5%, NYRT -8.5%, PIRS -7.3%, SYMC -6.5%, AEG -6.4%, ANTH -6.2%, OMER -5.8%, ELF -5.4%, HOLX -4.9%, QUIK -4.2%, RXII -3.7%, CPA -3.6%, SND -3.6%, BT -3.3%, KSS -3%, AGTC -2.5%, TEF -2.5%,TEF -2.5%, RLGT -2.4%, CFMS -2.3%, RTK -2.2%,ENB -1.9%, DDS -1.9%, AMBC -1.8%, BITA -1.7%,VSTM -1.6%, TIER -1.6%, CDTX -1.4%, ENV -1%,IMMU -1%, NDRM -1%
- STRP -20% (confirms agreement to be acquired by Verizon (VZ) for $184.00/share in stock)
- SAN -2.5%, BCS -2.4%, BBVA -2.1%, RBS -1.6%, ING-1.5%, DB -1.3%, CS -0.7%
- ITUS -41.2% (proposed registered public offering of its common stock)
- CNAT -13.8% (to offer and sell shares of its common stock in an underwritten public offering)
- ABR -7% (plans to make a public offering of 9,500,000 shares of its common stock)
- SP -6% (announces certain existing stockholders intend to offer for sale 3.6 mln shares of its common stock in a secondary offering)
- JWN -3% (in sympathy with M)
- BCRX -1.8% ( files for 11,710,951 share common stock offering by holders)
- BFAM -1.7% (prices 4.15 mln common stock offering by selling stockholders)
- CVTI -1.1% (US District Court for the Southern District of Ohio issued a pre-trial decision against one of its subsidiaries relating to a cargo claim incurred in 2008; co is reviewing its options regarding further appeals)
- MTBC -1% (announces $2.3 mln registered direct offering at $2.30 per share)
- MZOR -6.3% (downgraded to Market Perform from Outperform at Wells Fargo)
- SNY -3.7% (downgraded to Hold from Buy at Berenberg)
- YY -2.6% (downgraded to Neutral from Overweight at JP Morgan)
- ACIA -2.5% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- MEOH -1.1% (initiated with a Underperform at Bernstein)
In reaction to strong earnings/guidance:
- SGMO +39.1%, (also announced strategic collaboration with Pfizer), RELY +22.4%, CUR +15.3%, XONE +14.5%, CAAS +11.5%, PEGA +9.4%,LIVE +9.2%, LPSN +7.5%, CCXI +7.5%, STML +6.4%,XON +4.3%, QBAK +4.3%, PFIE +3.7%, ASM +3.2%,BSTG +3.2%, NTES +3.1%, BTX +3%, MGA +2.9%,WFM +2.8%, VUZI +2.7%, BAM +2.7%, SCLN +2.6%,GALE +2.6%, INO +2.5%, CALL +2.5%, AYX +2.5%,CORI +2.5%, HIMX +2.2%, EEP +2%, FBIO +1.9%, OA +1.9%, ATH +1.8%, ICUI +1.7%, TTGT +1.7%, SNDR +1.6%, RUN +1.2%, CDEV +1.2%, PCYG +1.2%, CBIO +1.2%
- MSLI +68.4% (to be acquired by Norgine B.V. for $1.65 per share in cash)
- GFI +1.8%, GOLD +1.7%, AU +1.6%, SSRI +1.4%, AG+1.3%, FCX +1.3%, GDX +0.8%, RIO +0.8%, BBL +0.7%
- SYN +35.4% (FDA has granted a Breakthrough Therapy Designation for SYN-004)
- PED +34% (continued strength)
- SYMX +25.8% (enters into a Technology License Agreement with Australian Future Energy for a large-scale project to be located in Australia)
- IPCI +6.8% (receives final FDA approval for its ANDA for quetiapine fumarate extended-release tablets)
- MRK +2.7% (confirms FDA approval of KEYTRUDA (pembrolizumab) as first-line combination therapy with pemetrexed and carboplatin for patients with metastatic NSCLC irrespective of PD-L1 expression)
- NMM +2.3% (provides update for acquisition of 14-Vessel container fleet from Rickmers Maritime)
- ORLY +1% (to increase the authorization amount under its share repurchase program by an additional $1 billion, raising the aggregate authorization under the program to $8.75 billion)
- MYL +1% (in sympathy with TEVA)
- YELP +2.9% (upgraded to Buy from Neutral at Citigroup)
- NBL +1.5% (upgraded to Buy from Neutral at BofA/Merrill)
- FOXA +1.4% (upgraded to Buy from Neutral at Rosenblatt)
- OMF +1.1% (upgraded to Buy from Underperform at BofA/Merrill)
- CAT +0.9% (upgraded to Buy from Neutral at BofA/Merrill)
- XOM +0.8% (upgraded to Buy from Neutral at BofA/Merrill)
Subject: Fwd:>>> Carrefour - Update - stock is not trading as expected - don't break resi
stock didn't closed below the 20.90 - and managed to break the downside trend, look more bullish here could trade higher - have a look :From: LAURENT CHEKROUN (MAKOR SECURITIES LO) At: 05/04/17 16:38:22Subject: Fwd:>>> Carrefour - Update - stock is not trading as expected - don't break resi
Stock is underpressure this pm, tested again its 50d MA and didn't manage to break it again today...see a support on 20.90...look bearish if we close below the 20.90From: LAURENT CHEKROUN (MAKOR SECURITIES LO) At: 05/03/17 09:32:53To: LAURENT CHEKROUN (MAKOR SECURITIES LO)
Subject: Fwd:>>> Carrefour - Stock has massively underperformed - Time to Buy to play reb
Carrefour - still trading in Downtrend range move not validate yet - but Outperfoning slightly todayFrom: LAURENT CHEKROUN (MAKOR SECURITIES LO) At: 05/02/17 12:18:19Subject: Fwd:>>> Carrefour - Stock has massively underperformed - Time to Buy to play rebound
>>> Carrefour - Stock has massively underperformed - trading better since investor day* CA Underperf EurosToxx 50 by 14% YTD & 23.5% on 1y, at the same time SXRP Underperf. only 5% & 13%,* French env. for Food Retail has been tought recently but end of uncertainties with the election we can hope some better momentum and some quick measures to boost consumption.* Carrefour look confident situation will improve during the year.* Macron scenario is smal positive but should help the sentiment...even if biggest part of the move has been played after the 1st round of the election.* Stock trading more than 8% below its average 3y PE, 12.95 vs 14.2* Chart configuration - Stock look to have bottomed and rebound on long support and find resistanceon its 50d MA (+/- 21.80) if we break this level (need to close above the 21.85) we can quickly test the 200d MA (22.60) with a gap to fill (22.36/22.50), next resistance 23.07, 23.29, 23.75* Consensus in the Street is still mixed some banks (UBS) still thinks Carrefour will be impact by margin pressure, few banks are more positive thinking that new models implemented by the group will drive some more growth, less depedance to hyper will help improve the sentiment (increase of eCommerce & new concept)Chart :
- SGMO +40.2%, PED +35.1%, RELY +26.5%, CUR+15.3%, SUNW +11.6%, CAAS +11.5%, PEGA +11.4%,XONE +7.9%, CCXI +7.5%, LPSN +6.9%, SCLN +4.6%,NTES +3.9%, PFIE +3.7%, WFM +3.4%, ASM +3.2%,BSTG +3.2%, MRK +3.1%, BTX +3%, VUZI +2.7%, INO+2.5%, CALL +2.5%, AYX +2.5%, CORI +2.5%, NMM+2.3%, RLGT +2.3%, ATH +2.3%, XON +2.2%, GFI+2.1%, TEVA +2.1%, HAL +2%, EEP +2%, MYL +1.9%,IOTS +1.9%, FBIO +1.9%, MTBC +1.7%, ICUI +1.7%,TTGT +1.7%, GOLD +1.6%, SNDR +1.6%, AU +1.5%,RIG +1.4%, AG +1.4%, CHK +1.4%, WLL +1.3%, PCYG+1.2%, TRXC +1.1%, CAT +1.1%, BHP +1.1%, ORLY+1%, GDX +1%, RIO +1%, WATT +1%, VRX +0.9%,FCX +0.9%
- ITUS -35.3%, NH -24.4%, SNAP -21%, STRP -20.5%,BCEI -16.8%, KGJI -16.7%, QTM -16.6%, MNKD-15.6%, RGSE -15.6%, CNAT -15.1%, AVNW -14.6%,VSTO -13.6%, FRSH -11.8%, RESN -11.5%, NYRT-9.7%, BITA -9.5%, SANW -8.3%, NVCN -7.9%, HOLX-7.1%, ABR -6.8%, ANTH -6.2%, VSTM -5.7%, SP-5.5%, SYMC -5.3%, ELF -5.1%, AEG -5.1%, QUIK-4.2%, OMER -4%, RXII -3.7%, CPA -3.6%, SND -3.6%,BT -3.5%, RUN -2.8%, AGTC -2.5%, STML -2.5%, TEF-2.5%, TEF -2.5%, SCON -2.4%, STM -2.3%, CFMS-2.3%, GALE -2.3%, RTK -2.2%, AFSI -1.8%, BCRX-1.8%, BCS -1.8%, AMBC -1.8%, TIER -1.6%, HIMX-1.5%, CDTX -1.4%, RBS -1.3%, BFAM -1.1%, CVTI-1.1%, MEOH -1.1%, SAN -1%, IMMU -1%, PIRS -1%,NDRM -1%
- Reports Q1 (Apr) earnings of $0.24 per share, excluding non-recurring items, $0.12 worse than the Capital IQ Consensus of $0.36; revenues fell 7.5% year/year to $5.34 bln vs the $5.49 bln Capital IQ Consensus.
- Comparable sales on an owned basis were down 5.2 percent in the first quarter and down 4.6 percent on an owned plus licensed basis vs. ests near -3%
- Co reaffirms guidance for FY18, sees EPS of $2.90-3.15 vs. $3.06 Capital IQ Consensus Estimate; sees FY18 revs of down 3.2-4.3% to ~$24.67-24.95 bln vs. $24.81 bln Capital IQ Consensus; comps down 2.2-3.3% or 2-3% including licenses.
- "Our first quarter sales and earnings results were consistent with our expectations, and we remain on track to meet our 2017 guidance. We are encouraged by the performance of the pilot programs we tested last year in categories like women's shoes, fine jewelry, and furniture and mattresses. We look forward to expanding these successful initiatives nationally this year and anticipate they will have a measurable impact on our performance starting in the second quarter, building through the fall. Additionally, our digital platforms showed continued strong growth in the first quarter," said Jeff Gennette, president and chief executive officer of Macy's, Inc. "In 2017, we are focused on taking actions to stabilize our brick and mortar business, including the testing and iteration of additional pilot programs in order to bring them to scale in future years. At the same time, we will invest to aggressively grow our digital and mobile business, while continuing the integration of our online and offline experience to allow our customers to shop the way they live.
After Hours Summary: WFM +3% following earnings/guidance and dividend/buyback/CFO news... SNAP -23%, MNKD -19%, SYMC -7%, ELF -6% following earnings/guidanceAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: SGMO +42.5% (also announced strategic collaboration with Pfizer), RELY +26.5%, PEGA +11.4%, XONE +10.5%, SCLN +4.6%, PFIE +4.5% (light volume), LPSN +4.4% (ticking higher), WFM +3.2% (also increases dividend, announces share repurchase; updates strategic initiations; names new CFO), ASM +3.2% (light volume), XON +2.8%, VUZI +2.7%, AYX +2.5%, RLGT +2.3%, ATH +2.3%, OMER +2.2%, DRYS +2.1%, EEP +2%, INO +1.7%, PCYG +1.2%, IOTS +1% (thinly traded), WATT +1%
Companies trading higher in after hours in reaction to news: PED +50.5% (continued strength - filed 10-Q and regained NYSE compliance today), MRK +3.1% (confirms FDA approval of KEYTRUDA (pembrolizumab) as first-line combination therapy with pemetrexed and carboplatin for patients with metastatic NSCLC irrespective of PD-L1 expression), NMM +2.3% (light volume; provides update for acquisition of 14-Vessel container fleet from Rickmers Maritime), ORLY +1% (to increase the authorization amount under its share repurchase program by an additional $1 billion, raising the aggregate authorization under the program to $8.75 billion)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: NH -24.4%, SNAP -23.2%, MNKD -18.8%, BCEI -16.8% (ticking lower), KGJI -16.7%, RGSE -16.3%, AVNW -16%, FRSH -11.8%, RESN -11.5% (light volume), NYRT -9.7%, NVCN -7.9%, HOLX -7.5%, SYMC -7.2%, ELF -6.2%, ANTH -6.2%, QUIK -4.2%, RUN -3.3%, IMMU -2.6%, STML -2.5% (light volume), AMBC -1.8%
Companies trading lower in after hours in reaction to news: ITUS -35.3% (proposed registered public offering of its common stock), CNAT -14.8% (to offer and sell shares of its common stock in an underwritten public offering), MTBC -4.6% (announces $2.3 mln registered direct offering at $2.30 per share), SP -4.6% (announces certain existing stockholders intend to offer for sale 3.6 mln shares of its common stock in a secondary offering), ABR -3.3% (plans to make a public offering of 9,500,000 shares of its common stock), BCRX -1.8% (files for 11,710,951 share common stock offering by holders), CVTI -1.1% (US District Court for the Southern District of Ohio issued a pre-trial decision against one of its subsidiaries relating to a cargo claim incurred in 2008; co is reviewing its options regarding further appeals), MEOH -1.1% (initiated with Underperform at Bernstein; tgt $36), USFD -0.7% (commences 35 mln common stock offering by Clayton, Dubilier & Rice and KKR and certain members of management and the board)
![]()
- Post-earnings gainers: SGMO +46%, PEGA +6.9%, IOTS +6.7%, LPSN +4.4%, CUR +4%, ASYS +3.3%, DRRX +3%, VSTM +2.5%, RLGT +2.3%, WFM +2.1%
- Post-earnings losers: NH -41.9%, SNAP -24.3%, RGSE -20%, BCEI -19.4%, FRSH -13.8%, MNKD -11.9%, AVNW -9.7%,SYMC -6.8%, NVCN -6.1%, GALE -5.5%, ANTH -4.9%, ELF -4.6%, FOXA -4.3%, AGTC -2.5%